✦ LIBER ✦

A phase II study of UFT with leucovorin administered as a twice daily schedule in the treatment of patients with metastatic colorectal cancer

✍ Scribed by Hoff, P M; Kopetz, S; Thomas, M B; Langleben, A; Rinaldi, D; Anthony, L; Wolff, R A; Lassere, Y; Abbruzzese, J L

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study of oxaliplatin, UFT, and

✍ Ester J. M. Siemerink; Annemieke F. J. Drenth; Nanno H. Mulder; John T. M. Plukk 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 245 KB

‘A phase II study of oral uracil/ftorafu

✍ Bennouna, J; Perrier, H; Paillot, B; Priou, F; Jacob, J H; Hebbar, M; Bordenave, 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 111 KB

Bioavailability and phase II study of or

✍ Neal J. Meropol; Daryl S. Sonnichsen; Martin J. Birkhofer; Irene Ferreira; Diane 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 30 KB

Bioavailability and phase II study of or

✍ Neal J. Meropol; Daryl S. Sonnichsen; Martin J. Birkhofer; Irene Ferreira; Diane 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 122 KB

A phase II pharmacodynamic study of pyra

✍ Robert Pelley; Ram Ganapathi; Laura Wood; Lisa Rybicki; Denise McLain; G. Thomas 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 76 KB

A multicenter phase II study of irinotec

✍ JuanJosé Reina; Jorge Aparicio; Javier Salvador; JoséMaríaPuerto Pica; Antonio R 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 192 KB